JP2024541701A5 - - Google Patents
Info
- Publication number
- JP2024541701A5 JP2024541701A5 JP2024553275A JP2024553275A JP2024541701A5 JP 2024541701 A5 JP2024541701 A5 JP 2024541701A5 JP 2024553275 A JP2024553275 A JP 2024553275A JP 2024553275 A JP2024553275 A JP 2024553275A JP 2024541701 A5 JP2024541701 A5 JP 2024541701A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- cso
- ribonucleotide
- modified
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163247556P | 2021-09-23 | 2021-09-23 | |
| US63/247,556 | 2021-09-23 | ||
| PCT/US2022/044406 WO2023049275A2 (en) | 2021-09-23 | 2022-09-22 | Cyclic structured oligonucleotides as therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541701A JP2024541701A (ja) | 2024-11-08 |
| JP2024541701A5 true JP2024541701A5 (cg-RX-API-DMAC7.html) | 2025-09-25 |
Family
ID=85721143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553275A Pending JP2024541701A (ja) | 2021-09-23 | 2022-09-22 | 治療剤としての環状構造化オリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250270550A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4405482A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024541701A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240082367A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118284697A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174342A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023049275A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260005403A (ko) * | 2023-03-22 | 2026-01-09 | 아르네이 사이언시스 엘엘씨 | 원형 프로드럭 핵산을 이용한 rna 치료제의 전달 |
| EP4731768A2 (en) * | 2023-06-23 | 2026-04-29 | Arnay Sciences, Llc | Delivery of rna therapeutics using ring-shaped nucleic acids |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658738A (en) * | 1994-05-31 | 1997-08-19 | Becton Dickinson And Company | Bi-directional oligonucleotides that bind thrombin |
| ES2109177B1 (es) * | 1995-10-11 | 1998-07-16 | Univ Barcelona | Procedimiento general de preparacion de oligonucleotidos ciclicos e intermedios para el mismo. |
| US6383752B1 (en) * | 1999-03-31 | 2002-05-07 | Hybridon, Inc. | Pseudo-cyclic oligonucleobases |
| EP1316607A1 (en) * | 1999-03-31 | 2003-06-04 | Hybridon, Inc. | Pseudo-cyclic oligonucleobases for inhibiting tumor growth |
| AU770615B2 (en) * | 1999-03-31 | 2004-02-26 | Hybridon, Inc. | Pseudo-cyclic oligonucleobases |
| JP3976742B2 (ja) * | 2004-02-27 | 2007-09-19 | 江守商事株式会社 | インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド |
| FR2933410B1 (fr) * | 2008-07-04 | 2010-08-20 | Biomerieux Sa | Nouvelle sonde de detection |
| WO2010084371A1 (en) * | 2009-01-26 | 2010-07-29 | Mitoprod | Novel circular interfering rna molecules |
| WO2012102616A1 (en) * | 2011-01-28 | 2012-08-02 | Flexgen B.V. | Heterodirectional polynucleotides |
| US20140128449A1 (en) * | 2011-04-07 | 2014-05-08 | The Board Of Regents Of The University Of Texas System | Oligonucleotide modulation of splicing |
| PL2992098T3 (pl) * | 2013-05-01 | 2019-09-30 | Ionis Pharmaceuticals, Inc. | Kompozycje i sposoby modulowania ekspresji hbv i ttr |
| UY37376A (es) * | 2016-08-26 | 2018-03-23 | Amgen Inc | Construcciones de arni para inhibir expresión de asgr1 y métodos para su uso |
-
2022
- 2022-09-22 KR KR1020247013302A patent/KR20240082367A/ko active Pending
- 2022-09-22 JP JP2024553275A patent/JP2024541701A/ja active Pending
- 2022-09-22 WO PCT/US2022/044406 patent/WO2023049275A2/en not_active Ceased
- 2022-09-22 CN CN202280077557.8A patent/CN118284697A/zh active Pending
- 2022-09-22 EP EP22873585.8A patent/EP4405482A4/en active Pending
- 2022-09-22 CA CA3174342A patent/CA3174342A1/en active Pending
-
2024
- 2024-03-21 US US18/612,655 patent/US20250270550A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5805088B2 (ja) | 遺伝子発現を阻害する組成物およびその使用 | |
| Wagner et al. | Potent and selective inhibition of gene expression by an antisense heptanucleotide | |
| JP5669897B2 (ja) | Tlr7およびtlr8に対する安定化免疫調節rna(simra)化合物 | |
| TWI695066B (zh) | 用於抑制b型肝炎病毒基因表現之組合物及方法 | |
| CN1604795B (zh) | 具有提高的活性的组合基序免疫刺激寡肽 | |
| US8552167B2 (en) | Multifunctional aptamer-nucleic acid nanostructures for tumor-targeted killing | |
| US20110059067A1 (en) | Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides | |
| JPH08510900A (ja) | 改良された抗インフルエンザ活性を有する修飾オリゴヌクレオチド | |
| US7060690B2 (en) | Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof | |
| JP2009521208A (ja) | ヒトil−12サイトカインファミリーに対するアプタマーおよびその自己免疫関連疾患治療薬としての使用 | |
| JP2008514647A (ja) | 二本鎖リボ核酸によって炎症性疾患を治療する方法 | |
| CN102686729A (zh) | 用于治疗hsf1相关疾病的有机组合物 | |
| US20230340496A1 (en) | Aptamer template and method for preparing aptamer by using same | |
| TW201919654A (zh) | 用於抑制α-ENaC表現之RNAi試劑及使用方法 | |
| KR20110017005A (ko) | Tgf-베타 수용체 유전자 발현 억제용 조성물 및 방법 | |
| CN114846142A (zh) | 用于抑制β-ENaC表达的RNAi试剂、其组合物和使用方法 | |
| CN112055598A (zh) | 用于抑制gys2表达的组合物和方法 | |
| JP2007527246A (ja) | ヒトil−12サイトカインファミリーに対するアプタマーおよび自己免疫疾患の治療剤としてのそれらの使用 | |
| US20030203356A1 (en) | RNase L activator-antisense complexes | |
| US7910563B2 (en) | Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA | |
| CN103597075A (zh) | 用于选择性地杀伤细胞的生物活性核苷酸分子、其用途及应用试剂盒 | |
| KR101986705B1 (ko) | 압타머 제조 방법 | |
| AU781297B2 (en) | Chimeric DNA/RNA ribozymes containing propanediol | |
| JP2024516575A5 (cg-RX-API-DMAC7.html) | ||
| JP2024526189A (ja) | 予防および治療のためのg-四重鎖含有オリゴヌクレオチド |